Mirabegron 223673-61-8 Inhibitor Neuronal teeb liab
Kev Them Nyiaj:T / T, L / C
Khoom Keeb Kwm:Tuam Tshoj
Shipping Chaw nres nkoj:Beijing / Shanghai / Hangzhou
Muaj peev xwm ntau lawm:100kg / hli
Order (MOQ):25kg ua
Lub Sijhawm Lead:3 Hnub Ua Haujlwm
Kev cia khoom:Khaws rau hauv qhov chaw txias, qhuav, chav sov.
Cov khoom siv pob:nruas
Pob loj:25kg / nruas
Cov ntaub ntawv kev nyab xeeb:Tsis yog khoom txaus ntshai
Taw qhia
Mirabegron, yog ib qho beta-3 adrenergic receptor agonist, uas txhawb nqa cov beta-3 adrenergic receptor thiab so lub detrusor du nqaij, yog li ua rau lub zais zis muaj peev xwm thiab siv los kho cov tsos mob ntawm lub zais zis ntau dhau (OAB), xws li kev xav tsis meej, ceev ceev, thiab zaus.
Nws cov txiaj ntsig zoo ib yam li cov tshuaj antimuscarinic xws li solifenacin lossis tolterodine.
Specification (USP/EP)
| Yam khoom | Specification |
| Qhov tshwm sim | Dawb kom tawm hmoov dawb |
| Kev txheeb xyuas | IR, HPLC |
| Cov ntsiab lus dej | 0.5% NMT |
| Residue ntawm ignition | NMT 0.1% |
| Hnyav hlau | NMT 20 ppm |
| Palladium cov ntsiab lus | NMT 20 ppm |
| Kho qhov muag isomer | 0.5% NTM |
| Muaj feem xyuam | Z-168 *: NMT 0.15% |
| SC03610 *: NMT 0.15% | |
| Lwm yam tsis paub impurity: NMT 0.10% | |
| Tag nrho impurity: NMT 0.5% | |
| 2-(2-aminothianzol-4-yl) acetic acid | NMT 0.1% |
| Residual kuab tshuaj | Methanol: NMT 0.3% |
| Ethyl acetate: NMT 0.5% | |
| THF: NMT 0.072% | |
| Benzene: NMT 0.0002% | |
| Toluene: NMT 0.089% | |
| Assay | 98.0% - 102.0% |
| PSD | D (0.5): 10μm - 30μm |
| D (0.9): 20μm - 80μm |
